Metabolic syndrome and other comorbidities in the structure of COVID-19 mortality in the Republic of Moldova (March-December 2020)

Authors

  • Mereuţă Ion Institutul de Fiziologie și Sanocreatologie, Universitatea de Stat de Medicină și Farmacie „N. Testemițanu”
  • Fedaș Vasile Universitatea de Stat de Medicină și Farmacie „N. Testemițanu”
  • Tomșa Anastasia Agenția Națională pentru Sănătate Publică
  • Cebotari Anghela Institutul de Fiziologie și Sanocreatologie

DOI:

https://doi.org/10.52692/1857-0011.2021.2-70.05

Keywords:

COVID-19, mortality, comorbidities, malignant tumors, diabetes, cardiovascular disease

Abstract

Metabolic syndrome and other co-morbidities in the structure of COVID-19 mortality in the Republic of Moldova (March-December 2020) The mortality of the population of the Republic of Moldova through COVID-19 in March-December 2020 made up 2846 (100%) people confirmed with SARS CoV-2 (women –1362/2846 (47,8%), men — 1484/2846 (52,2%). In the urban sector it is 1649/2846 (58,0%), including Chisinau — 1034/2846 (36,3%), Balti — 158/2846 (5,6%), in the rural sector — 1197/2846 (42%). Mortality in the age groups constituted for the age group of 30-70 years (men — 862/2846 (30,3%), women — 805/2846 (28,2%). The share of comorbidity was 1905/2846 (66,9%), the structure of the main diseases being: diseases of the cardiovascular system – 966/1905 (33,9%); diabetes mellitus – 523/1905 (27,5%); malignant tumors – 91/1905 (4,8%). In the age groups — 30-70 years: diseases of the circulatory system – 485/1905 (25.4%), diabetes – 335/1905 (17.6%), cancer – 62/1905 (3.3%)

Author Biographies

Mereuţă Ion, Institutul de Fiziologie și Sanocreatologie, Universitatea de Stat de Medicină și Farmacie „N. Testemițanu”

dr. hab. în șt. med., prof. univ

Fedaș Vasile, Universitatea de Stat de Medicină și Farmacie „N. Testemițanu”

dr. în șt. med

Tomșa Anastasia, Agenția Națională pentru Sănătate Publică

șef-adjunct direcție, direcția Management date în sănătate

Cebotari Anghela, Institutul de Fiziologie și Sanocreatologie

cercet. șt

References

Chen Z.-M. et al. Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus. World journal of pediatrics: WJP 2020.

Handbook of COVID-19 Prevention and Treatment,2020.

Stoermer M.G. Homology Models of the Papain-Like Protease PLpro from Coronavirus 2019-nCoV. 2020.

Wu F. et al. A new coronavirus associated with hu- man respiratory disease in China. Nature 2020.

Zhang H., Saranan K.M. et al. Deep learning based drug screening for novel coronavirus 2019-nCoV. 2020, 19.

Zhou P. et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020.

Zumla A., Hui D.S. et al. Reducing mortality from 2019-n CoV: host-directed therapies should be an option. The Lancet 2020, 395.

World Health Organization. Novel Coronavirus (2019-nCoV) situation reports. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports/ (Accesat 02.03.2021).

https://chemrxiv.org/articles/inhibitors for Novel Coronavirus Protease Indentified by Virtual Screning of 687 Million Compounds/11923239/1.

COVID-19 и метаболический синдром: низкоуглеводное питание против коронавируса. În: https://lchf.ru/30703 (Accesat: 06.09.2020).

Downloads

Published

2021-09-25

Issue

Vol. 70 No. 2 (2021): Medical Sciences

Section

Research Article

License

Copyright (c) 2021 Bulletin of the Academy of Sciences of Moldova. Medical Sciences

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.